US Patent Issued to University of Tartu on March 24 for "Bi-specific extracellular matrix binding peptides and methods of use thereof" (Estonian Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,888, issued on March 24, was assigned to University of Tartu (Tartu, Estonia).

"Bi-specific extracellular matrix binding peptides and methods of use thereof" was invented by Tambet Teesalu (Tartu, Estonia) and Prakash Lingasamy (Tartu, Estonia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compositions, compounds, and methods relating to peptides that can target and home to cancer, tumors, and extracellular matrix. This is based on the discovery of peptides that can specifically bind to fibronectin extra domain B (FN-EDB), tenascin-C C domain (TNC-C), or both."

The patent was filed on Feb. 3, 2020, under Application No. 17/428,484. ...